Active hepatitis B virus vaccination in the prevention of viral reactivation in liver transplantation recipients with previous hepatitis B infection: a cohort study
BACKGROUND AND AIM OF THE STUDY: For many years, the standard treatment following liver transplantation for hepatitis B has been a combination of hepatitis B immunoglobulin and nucleos(t)ide analogues such as entecavir and tenofovir. However, because of the high costs and logistical challenges of l...
Saved in:
Main Authors: | Eric Adler, Yasemin Krucker, Mirjam Kolev, Nasser Semmo |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2025-05-01
|
Series: | Swiss Medical Weekly |
Online Access: | https://smw.ch/index.php/smw/article/view/4116 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccination against viral hepatitis b in pediatric liver transplant recipients
by: V. I. Zhilkin, et al.
Published: (2018-01-01) -
Viral Hepatitis in Solid Organ Transplant Recipients
by: VanWagner, Lisa B., et al.
Published: (2011) -
Outcome of kidney transplant recipients with a history of hepatitis B and C viruses
by: Hajar Fitah, et al.
Published: (2025-05-01) -
Vaccination against viral hepatitis B in patients undergoing liver transplantation for hepatitis B-unassociated causes
by: V. E. Syutkin, et al.
Published: (2018-08-01) -
Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)